natural alternatives to glp-1 weight-loss drugs GLP-TRIM - A Alternative Research shows GLP-1 drugs are
Description
Discover the benefits of GLP-1 medications like Wegovy and Zepbound at Austin Thyroid & Endocrinology
We comprehensively mapped the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound)
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
This supports that pharmacies are permitted to compound GLP-1 drugs under section 503A of the Act, provided they adhere to specific conditions outlined by the FDA
ADDITIONAL DETAILS: Live Probiotics, Prebiotic Fiber, and a Key Postbiotic for Daily Support
The problem is what the studies actually show.
